Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher

Published 02/04/2024, 19:45
Updated 02/04/2024, 21:10
© Reuters.  Nasdaq Down Over 1%; VivoPower International Shares Spike Higher

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday.

The Dow traded down 1.07% to 39,142.53 while the NASDAQ fell 1.14% to 16,209.12. The S&P 500 also fell, dropping, 0.85% to 5,199.28.

Check This Out: Wynn Resorts, Hilton Worldwide And An Energy Stock On CNBC's 'Final Trades'

Leading and Lagging Sectors

Energy shares jumped by 0.6% on Tuesday.

In trading on Tuesday, health care shares fell by 2%.

Top Headline

The number of job openings rose by 8,000 from the prior month to 8.756 million in February compared to market estimates of 8.75 million.

Equities Trading UP

VivoPower International PLC (NASDAQ: VVPR) shares shot up 385% to $7.08 after the company's Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited.

Shares of VirTra, Inc. (NASDAQ: VTSI) got a boost, surging 33% to $12.72 after the company reported better-than-expected fourth-quarter results.

MSP Recovery, Inc. (NASDAQ: LIFW) shares were also up, gaining 30% to $0.87 after a 13G filing showed Palantir Technologies reported a 6.5% stake in the company as of March 22, 2024.

Equities Trading DOWN

Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares dropped 76% to $3.2501 after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.

Shares of Gritstone bio, Inc. (NASDAQ: GRTS) were down 50% to $1.1850 after the company announced a $32.5 million underwritten public offering of 8,333,333 shares of common stock and accompanying common warrants at $1.50 per share and accompanying common warrant.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Verve Therapeutics, Inc. (NASDAQ: VERV) was down, falling 36% to $8.15 amid the company pausing enrollment in its Heart-1 Phase 1b clinical trial after a participant experienced a Grade 3 drug-induced transient increase in serum alanine aminotransferase as well as a serious adverse event.

Also Check This Out: Bitcoin Falls Below $66,000; Axelar Becomes Top Loser

Commodities

In commodity news, oil traded up 1.7% to $85.13 while gold traded up 1.6% at $2,292.70.

Silver traded up 3.3% to $25.91 on Tuesday, while copper rose 0.5% to $4.0680.

Euro zone

European shares closed lower today. The eurozone’s STOXX 600 fell 0.80%, London’s FTSE 100 fell 0.22% while Spain’s IBEX 35 Index fell 0.89% The German DAX fell 1.13% French CAC 40 fell 0.92% while Italy’s FTSE MIB Index fell 1.22%.

The HCOB manufacturing PMI for Eurozone rose to 46.1 in March versus a preliminary reading of 45.7. Median consumer expectations for Eurozone inflation over the next 12 months eased to 3.1% in February. The HCOB Germany manufacturing PMI was revised higher to 41.9 in March versus a preliminary level of 41.6, while French manufacturing PMI declined to 46.2 in March versus 47.1 a month ago.

The S&P Global UK Manufacturing PMI rose to 50.3 in March versus a preliminary reading of 49.9, while consumer credit in the UK rose by £1.378 billion in February. The Nationwide House Price Index in the UK increased by 1.6% year-over-year in March following a 1.2% gain in February.

Asia Pacific Markets

Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 gaining 0.09%, Hong Kong’s Hang Seng Index gaining 2.36%, China’s Shanghai Composite Index falling 0.08% and India’s S&P BSE Sensex falling 0.2%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The HSBC Indian manufacturing PMI was revised lower to 59.1 in March compared to a preliminary reading of 59.2.

Economics

U.S. factory orders increased by 1.4% from the prior month to $576.8 billion in February, following a revised 3.8% decline in January.

The number of job openings rose by 8,000 from the prior month to 8.756 million in February compared to market estimates of 8.75 million.

Now Read This: Insiders Buying Westlake Chemical Partners And 2 Other Stocks

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.